Drugs, key data
This eight-page document, produced in 2013 by the OFDT, provides the most relevant figures for measuring and providing a quick overview of drug-related phenomena.
- Drugs, Key Data - 7th edition (june 2017)
- Drugs, Key Data - 6th edition (june 2015)
- Drugs, Key Data - 5th edition (june 2013)
- Drugs, Key Data - 3rd edition (june 2010)
- Drugs, Key Data - 1st edition (december 2007)
Drugs in Europe
What do the latest data tell us about the European drug market? What are the new trends in drug use among European adults and school students? What are the harms associated with drug use and what is being done to counter them? These and other questions are explored in the 2017 EMCDDA European Drug Report.
Country drug reports
Developed by the EMCDDA, in cooperation with the Reitox national focal points, these graphic-rich reports cover: drug use and public health problems; drug policy and responses and drug supply.
The European Union and the drug phenomenon
The European Union & the drug phenomenon : Frequently asked questions , joint publication between the EMCDDA and the European Commission, october 2010, 12 p.